Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Johnson & Johnson (JNJ_KZ)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
147.84 -1.16    -0.78%
12:37:00 - Closed. Currency in USD ( Disclaimer )
  • Volume: 11
  • Bid/Ask: 146.39 / 147.84
  • Day's Range: 147.22 - 147.98
Type:  Equity
Market:  Kazakhstan
ISIN:  US4781601046 
J&J 147.84 -1.16 -0.78%

JNJ_KZ Balance Sheet

 
Assess the latest Johnson & Johnson balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced JNJ Annual Report data, financial summaries and charts are available for Johnson & Johnson investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2023
31/12
 2023
01/10
 2023
02/07
 2023
02/04
Total Current Assets - 53703 60567 64388
Cash and Short Term Investments 23511 23511 28505 24613
Cash - - - -
Cash & Equivalents - 19728 21183 19170
Short Term Investments - 3783 7322 5443
Total Receivables, Net - 14798 16777 16350
Accounts Receivables - Trade, Net - 14798 16777 16350
Total Inventory - 11198 12888 12809
Prepaid Expenses - 4196 2397 2921
Other Current Assets, Total - - - 7695
Total Assets - 166061 191686 195969
Property/Plant/Equipment, Total - Net - 18821 20576 20174
Property/Plant/Equipment, Total - Gross - 45626 51218 50367
Accumulated Depreciation, Total - -26805 -30642 -30193
Goodwill, Net - 36124 45440 45575
Intangibles, Net - 35021 46246 47448
Long Term Investments - 4708 1240 1229
Note Receivable - Long Term - - - -
Other Long Term Assets, Total - 8425 8838 8338
Other Assets, Total - 9442 12212 18414
Total Current Liabilities - 44370 54170 60373
Accounts Payable - 8355 10443 9909
Payable/Accrued - - - -
Accrued Expenses - 29246 29339 28219
Notes Payable/Short Term Debt - 2000 9800 16900
Current Port. of LT Debt/Capital Leases - 1870 1901 1079
Other Current liabilities, Total - 2899 2687 4266
Total Liabilities - 94833 115277 125100
Total Long Term Debt - 26051 33901 34928
Long Term Debt - 26051 33901 34928
Capital Lease Obligations - - - -
Deferred Income Tax - 2623 3627 4417
Minority Interest - - 1260 -
Other Liabilities, Total - 17919 10618 7403
Total Equity 71228 71228 76409 70869
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 3120 3120 3120
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) - 152536 129381 124558
Treasury Stock - Common - -75648 -44217 -44183
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 71228 -8780 -11875 -12626
Total Liabilities & Shareholders' Equity - 166061 191686 195969
Total Common Shares Outstanding 2407.08 2407.18 2598.14 2598.32
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

JNJ Price Commentary

Write your thoughts about Johnson & Johnson
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Andre Van Laer
Andre Van Laer Aug 25, 2023 20:07
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Kenvur buyers return to jnj? Double discount/double dip...? LOL?
Reply
0 0
Report
Nik Daniel
Nik Daniel Feb 18, 2023 7:43
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Niceee movement
Reply
0 0
Report
Lee Baldwin
Lee Baldwin Aug 24, 2022 15:50
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Interest rates?
Reply
0 0
Report
ifigeneia ifigeneia
ifigeneia ifigeneia Oct 15, 2021 16:00
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
FDA approved finally. Few minutes ago!!!!
Reply
2 0
Report
Lee Baldwin
Lee Baldwin Oct 15, 2021 16:00
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What?
Reply
0 0
Report
Lukas Bednall
Lukas Bednall Sep 22, 2021 19:15
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Invested in J&J a couples years back and have closely followed the pharmaceutical industry. Found a company by the name of SpectrumX which has an IPO set for November. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trails for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
Reply
3 0
Report
ifigeneia ifigeneia
ifigeneia ifigeneia Sep 22, 2021 19:15
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
To entry in Spectrum or not? What do you think?
Reply
0 0
Report
Adam Whipps
Adam Whipps Sep 22, 2021 19:15
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Checking it out looks like a good punt
Reply
0 0
Report
Oc Masai
Oc Masai Apr 24, 2021 11:07
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Good job JNJ. move forward bullish
Reply
2 0
Report
Lee Baldwin
Lee Baldwin Dec 29, 2020 15:31
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Stock split???
Reply
0 0
Report
Sinisa Galesic
Sinisa Galesic Dec 22, 2020 23:01
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Where we go next?
Reply
0 0
Report
Paul Strong
Paul Strong Dec 22, 2020 23:01
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
AMC! But ultimately it’s your decision.
Reply
0 0
Report
Lee Baldwin
Lee Baldwin Oct 29, 2020 16:12
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Good buy. 0at this price
Reply
3 0
Report
AdrianQ Khew
AdrianQ Khew Jul 23, 2019 11:10
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
JNJ is going to Make a strong come back tonight!
Reply
4 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email